000 04013naa a22005057i 4500
001 UMUN-OA-20261005-MLS-060
003 local
005 20261005174906.0
006 m o d
007 cr||||||||||||
008 261005s2018 xx o u000 0 eng d
024 7 _a10.3748/wjg.v24.i35.4000
_2doi
035 _a(local)EuropePMC:PMC6148422
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aArchana Rastogi
_eauthor.
245 1 0 _aChanging role of histopathology in the diagnosis and management of hepatocellular carcinoma. /
_cArchana Rastogi.
264 1 _a[Place of publication not identified] :
_bBaishideng Publishing Group Inc,
_c2018.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aHepatocellular carcinoma (HCC) is one of the most common and fatal cancer in the world. HCC frequently presents with advanced disease, has a high recurrence rate and limited treatment options, which leads to very poor prognosis. This warrants urgent improvement in the diagnosis and treatment. Liver biopsy plays very important role in the diagnosis and prognosis of HCC, but with technical advancements and progression in the field of imaging, clinical guidelines have restricted the role of biopsy to very limited situations. Biopsy also has its own problems of needle tract seeding of tumor, small risk of complications, technical and sampling errors along with interpretative errors. Despite this, tissue analysis is often required because imaging is not always specific, limited expertise and lack of advanced imaging in many centers and limitations of imaging in the diagnosis of small, mixed and other variant forms of HCC. In addition, biopsy confirmation is often required for clinical trials of new drugs and targeted therapies. Tissue biomarkers along with certain morphological features, phenotypes and immune-phenotypes that serve as important prognostic and outcome predictors and as decisive factors for therapy decisions, add to the continuing role of histopathology. Advancements in cancer biology and development of molecular classification of HCC with clinic pathological correlation, lead to discovery of HCC phenotypic surrogates of prognostic and therapeutically significant molecular signatures. Thus tissue characteristics and morphology based correlates of molecular subtypes provide invaluable information for management and prognosis. This review thus focuses on the importance of histopathology and resurgence of role of biopsy in the diagnosis, management and prognostication of HCC.
540 _aCreative Commons Attribution-NonCommercial. See the linked licence for the applicable terms.
_uhttp://creativecommons.org/licenses/by-nc/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Medical Laboratory Science.
650 4 _aImmunohistochemistry
650 4 _aHepatocellular carcinoma
650 4 _aMolecular
650 4 _aDiagnosis
650 4 _aPrognosis
650 4 _aBiomarker
653 _aB. Sc. Medical Laboratory Science
653 _aUMUN open access collection
653 _ahistopathology
655 4 _aReview articles.
773 0 _tWorld journal of gastroenterology
_gVol. 24, no. 35, (2018), pages/article 4000-4013
_x1007-9327
856 4 0 _uhttps://europepmc.org/articles/PMC6148422
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC6148422
_qlocal
942 _n0
999 _c1202
_d1202